[1]
“A META-ANALYSIS STUDY OF POLYCHEMOTHERAPY VERSUS MONOCHEMOTHERAPY IN PATIENTS OF METASTATIC BREAST CANCER”, Int. J. Pharm. Sci. Drug Res., vol. 8, no. 3, pp. 134–143, May 2016, doi: 10.25004/IJPSDR.2016.080302.